Vaxxinity Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
VAXX Nasdaq 8731 https://vaxxinity.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Vaxxinity Inc

Vaxxinity Issues Shareholder Letter - Apr 19th, 2024 10:53 pm
Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock - Apr 19th, 2024 8:27 pm
Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting - Mar 28th, 2024 1:23 pm
Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates - Mar 27th, 2024 8:41 pm
Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024 - Mar 7th, 2024 3:32 pm
Vaxxinity’s Heart Health Innovation to Reduce LDL Cholesterol Levels - Feb 15th, 2024 4:29 pm
Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published - Feb 15th, 2024 1:00 pm
Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024 - Feb 13th, 2024 1:00 pm
Vaxxinity, UF Join Forces Against Neurodegenerative Diseases - Jan 30th, 2024 5:27 pm
Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida - Jan 30th, 2024 1:00 pm
Vaxxinity & UCF to Collaborate on Space Medicine Research - Jan 19th, 2024 7:32 pm
Vaxxinity Announces Collaboration on Space Medicine Research with University of Central Florida - Jan 18th, 2024 1:00 pm
Vaxxinity to Present at the 2024 J.P. Morgan Healthcare Conference - Jan 3rd, 2024 1:00 pm
The Zacks Analyst Blog Highlights Biogen, Prothena, AC Immune's and Vaxxinity - Dec 12th, 2023 2:10 pm
FOCUS-Researchers return to Alzheimer's vaccines, buoyed by recent drug success - Nov 20th, 2023 11:00 am
Vaxxinity to Present at Upcoming November Medical and Investor Conferences - Nov 13th, 2023 11:50 pm
Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update - Nov 8th, 2023 1:30 pm
Private companies invested in Vaxxinity, Inc. (NASDAQ:VAXX) copped the brunt of last week's US$41m market cap decline - Oct 10th, 2023 2:53 pm
Down -22.18% in 4 Weeks, Here's Why You Should You Buy the Dip in Vaxxinity, Inc. (VAXX) - Sep 7th, 2023 1:35 pm
Vaxxinity to Present at Upcoming Investor Conferences in September - Aug 29th, 2023 12:00 pm